1887

Abstract

Monitoring antibiotic-resistant bacteria (ARB) and understanding the effects of antimicrobial drugs on the human microbiome and resistome are crucial for public health. However, no study has investigated the association between antimicrobial treatment and the microbiome–resistome relationship in long-term care facilities, where residents act as reservoirs of ARB but are not included in the national surveillance for ARB. We conducted shotgun metagenome sequencing of oral and stool samples from long-term care facility residents and explored the effects of antimicrobial treatment on the human microbiome and resistome using two types of comparisons: cross-sectional comparisons based on antimicrobial treatment history in the past 6 months and within-subject comparisons between stool samples before, during and 2–4 weeks after treatment using a single antimicrobial drug. Cross-sectional analysis revealed two characteristics in the group with a history of antimicrobial treatment: the archaeon was the only taxon that significantly increased in abundance, and the total abundance of antimicrobial resistance genes (ARGs) was also significantly higher. Within-subject comparisons showed that taxonomic diversity did not decrease during treatment, suggesting that the effect of the prescription of a single antimicrobial drug in usual clinical treatment on the gut microbiota is likely to be smaller than previously thought, even among very elderly people. Additional analysis of the detection limit of ARGs revealed that they could not be detected when contig coverage was <2.0. This study is the first to report the effects of usual antimicrobial treatments on the microbiome and resistome of long-term care facility residents.

Funding
This study was supported by the:
  • Japan Agency for Medical Research and Development (Award 23fk0108606)
    • Principle Award Recipient: MotoyukiSugai
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001180
2024-02-20
2024-05-20
Loading full text...

Full text loading...

/deliver/fulltext/mgen/10/2/mgen001180.html?itemId=/content/journal/mgen/10.1099/mgen.0.001180&mimeType=html&fmt=ahah

References

  1. Blair JMA, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJV. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 2015; 13:42–51 [View Article] [PubMed]
    [Google Scholar]
  2. Sugden R, Kelly R, Davies S. Combatting antimicrobial resistance globally. Nat Microbiol 2016; 1:16187 [View Article] [PubMed]
    [Google Scholar]
  3. Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis 2019; 19:56–66 [View Article] [PubMed]
    [Google Scholar]
  4. Antimicrobial Resistance C Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399:629–655
    [Google Scholar]
  5. Willmann M, Vehreschild MJGT, Biehl LM, Vogel W, Dörfel D et al. Distinct impact of antibiotics on the gut microbiome and resistome: a longitudinal multicenter cohort study. BMC Biol 2019; 17:76 [View Article] [PubMed]
    [Google Scholar]
  6. Palleja A, Mikkelsen KH, Forslund SK, Kashani A, Allin KH et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat Microbiol 2018; 3:1255–1265 [View Article] [PubMed]
    [Google Scholar]
  7. Schwartz DJ, Langdon AE, Dantas G. Understanding the impact of antibiotic perturbation on the human microbiome. Genome Med 2020; 12:82 [View Article] [PubMed]
    [Google Scholar]
  8. Zaura E, Brandt BW, Teixeira de Mattos MJ, Buijs MJ, Caspers MPM et al. Same exposure but two radically different responses to antibiotics: resilience of the salivary microbiome versus long-term microbial shifts in feces. mBio 2015; 6:e01693–15 [View Article] [PubMed]
    [Google Scholar]
  9. Bonomo RA. Multiple antibiotic-resistant bacteria in long-term-care facilities: an emerging problem in the practice of infectious diseases. Clin Infect Dis 2000; 31:1414–1422 [View Article] [PubMed]
    [Google Scholar]
  10. Rooney PJ, O’Leary MC, Loughrey AC, McCalmont M, Smyth B et al. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J Antimicrob Chemother 2009; 64:635–641 [View Article] [PubMed]
    [Google Scholar]
  11. van den Dool C, Haenen A, Leenstra T, Wallinga J. The role of nursing homes in the spread of antimicrobial resistance over the healthcare network. Infect Control Hosp Epidemiol 2016; 37:761–767 [View Article] [PubMed]
    [Google Scholar]
  12. Kajihara T, Yahara K, Hirabayashi A, Shibayama K, Sugai M. Japan Nosocomial Infections Surveillance (JANIS): current status, International collaboration, and future directions for a comprehensive antimicrobial resistance surveillance system. Jpn J Infect Dis 2021; 74:87–96 [View Article] [PubMed]
    [Google Scholar]
  13. Kajihara T, Yahara K, Yoshikawa M, Haruta A, Kawada-Matsuo M et al. Oral and rectal colonization by antimicrobial-resistant gram-negative bacteria and their association with death among residents of long-term care facilities: a prospective, multicenter, observational, cohort study. Gerontology 2023; 69:261–272 [View Article] [PubMed]
    [Google Scholar]
  14. Saito R, Koyano S, Nagai R, Okamura N, Moriya K et al. Evaluation of a chromogenic agar medium for the detection of extended-spectrum ß-lactamase-producing Enterobacteriaceae. Lett Appl Microbiol 2010; 51:704–706 [View Article] [PubMed]
    [Google Scholar]
  15. Kim S-W, Suda W, Kim S, Oshima K, Fukuda S et al. Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res 2013; 20:241–253 [View Article] [PubMed]
    [Google Scholar]
  16. Suzuki Y, Nishijima S, Furuta Y, Yoshimura J, Suda W et al. Long-read metagenomic exploration of extrachromosomal mobile genetic elements in the human gut. Microbiome 2019; 7:119 [View Article] [PubMed]
    [Google Scholar]
  17. Li P-E, Lo C-C, Anderson JJ, Davenport KW, Bishop-Lilly KA et al. Enabling the democratization of the genomics revolution with a fully integrated web-based bioinformatics platform. Nucleic Acids Res 2017; 45:67–80 [View Article] [PubMed]
    [Google Scholar]
  18. Nurk S, Meleshko D, Korobeynikov A, Pevzner PA. metaSPAdes: a new versatile metagenomic assembler. Genome Res 2017; 27:824–834 [View Article] [PubMed]
    [Google Scholar]
  19. Beghini F, McIver LJ, Blanco-Míguez A, Dubois L, Asnicar F et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife 2021; 10:e65088 [View Article] [PubMed]
    [Google Scholar]
  20. Truong DT, Franzosa EA, Tickle TL, Scholz M, Weingart G et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat Methods 2015; 12:902–903 [View Article] [PubMed]
    [Google Scholar]
  21. Arango-Argoty G, Garner E, Pruden A, Heath LS, Vikesland P et al. DeepARG: a deep learning approach for predicting antibiotic resistance genes from metagenomic data. Microbiome 2018; 6:23 [View Article] [PubMed]
    [Google Scholar]
  22. Lee K, Raguideau S, Sirén K, Asnicar F, Cumbo F et al. Population-level impacts of antibiotic usage on the human gut microbiome. Nat Commun 2023; 14: [View Article]
    [Google Scholar]
  23. Mallick H, Rahnavard A, McIver LJ, Ma S, Zhang Y et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput Biol 2021; 17:e1009442 [View Article] [PubMed]
    [Google Scholar]
  24. von Meijenfeldt FAB, Arkhipova K, Cambuy DD, Coutinho FH, Dutilh BE. Robust taxonomic classification of uncharted microbial sequences and bins with CAT and BAT. Genome Biol 2019; 20: [View Article]
    [Google Scholar]
  25. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012; 9:357–359 [View Article] [PubMed]
    [Google Scholar]
  26. Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V et al. Twelve years of SAMtools and BCFtools. Gigascience 2021; 10:giab008 [View Article] [PubMed]
    [Google Scholar]
  27. Chibani CM, Mahnert A, Borrel G, Almeida A, Werner A et al. A catalogue of 1,167 genomes from the human gut archaeome. Nat Microbiol 2022; 7:48–61 [View Article] [PubMed]
    [Google Scholar]
  28. Samuel BS, Hansen EE, Manchester JK, Coutinho PM, Henrissat B et al. Genomic and metabolic adaptations of Methanobrevibacter smithii to the human gut. Proc Natl Acad Sci U S A 2007; 104:10643–10648 [View Article] [PubMed]
    [Google Scholar]
  29. Rooney AM, Raphenya AR, Melano RG, Seah C, Yee NR et al. Performance characteristics of next-generation sequencing for the detection of antimicrobial resistance determinants in Escherichia coli genomes and metagenomes. mSystems 2022; 7:e0002222 [View Article] [PubMed]
    [Google Scholar]
  30. Khelaifia S, Drancourt M. Susceptibility of archaea to antimicrobial agents: applications to clinical microbiology. Clin Microbiol Infect 2012; 18:841–848 [View Article] [PubMed]
    [Google Scholar]
  31. Dridi B, Fardeau ML, Ollivier B, Raoult D, Drancourt M. The antimicrobial resistance pattern of cultured human methanogens reflects the unique phylogenetic position of archaea. J Antimicrob Chemother 2011; 66:2038–2044 [View Article] [PubMed]
    [Google Scholar]
  32. Liu X, Mao B, Gu J, Wu J, Cui S et al. Blautia-a new functional genus with potential probiotic properties?. Gut Microbes 2021; 13:1–21 [View Article] [PubMed]
    [Google Scholar]
  33. Cui Y, Zhang L, Wang X, Yi Y, Shan Y et al. Roles of intestinal Parabacteroides in human health and diseases. FEMS Microbiol Lett 2022; 369:fnac072 [View Article] [PubMed]
    [Google Scholar]
  34. Amanatidou E, Matthews AC, Kuhlicke U, Neu TR, McEvoy JP et al. Biofilms facilitate cheating and social exploitation of β-lactam resistance in Escherichia coli. NPJ Biofilms Microbiomes 2019; 5:36 [View Article] [PubMed]
    [Google Scholar]
  35. Dulanto Chiang A, Dekker JP. From the pipeline to the bedside: advances and challenges in clinical metagenomics. J Infect Dis 2020; 221:S331–S340 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.001180
Loading
/content/journal/mgen/10.1099/mgen.0.001180
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

EXCEL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error